These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36196592)

  • 1. Evaluation of urinary neutrophil gelatinase-associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease.
    Troia R; Sabetti MC; Crosara S; Quintavalla C; Romito G; Mazzoldi C; Fidanzio F; Cescatti M; Bertazzolo W; Giunti M; Dondi F
    J Vet Intern Med; 2022 Nov; 36(6):2053-2062. PubMed ID: 36196592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease.
    Crosara S; Fidanzio F; Oricco S; Dondi F; Mazzoldi C; Monari E; Romito G; Sabetti MC; Troìa R; Quintavalla C
    Res Vet Sci; 2024 May; 171():105211. PubMed ID: 38458044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
    Druzhaeva N; Nemec Svete A; Ihan A; Pohar K; Domanjko Petrič A
    J Vet Intern Med; 2021 Sep; 35(5):2112-2122. PubMed ID: 34236111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
    Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
    BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron parameters analysis in dogs with myxomatous mitral valve disease.
    Kumiega E; A Kobak K; Noszczyk-Nowak A; Kasztura M
    BMC Vet Res; 2024 May; 20(1):210. PubMed ID: 38762716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
    PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease.
    Sabetti MC; Fidanzio F; Troìa R; Perissinotto L; Romito G; Mazzoldi C; Quintavalla C; Crosara S; Dondi F
    J Vet Cardiol; 2022 Jun; 41():57-69. PubMed ID: 35245876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine neutrophil gelatinase-associated lipocalin to diagnose and characterize acute kidney injury in dogs.
    Monari E; Troìa R; Magna L; Gruarin M; Grisetti C; Fernandez M; Balboni A; Giunti M; Dondi F
    J Vet Intern Med; 2020 Jan; 34(1):176-185. PubMed ID: 31705606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs.
    Szczepankiewicz B; Pasławska U; Siwińska N; Plens K; Pasławski R
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320321995082. PubMed ID: 33730896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary neutrophil gelatinase-associated lipocalin as an early biomarker for acute kidney injury in dogs.
    Scheemaeker S; Meyer E; Schoeman JP; Defauw P; Duchateau L; Daminet S
    Vet J; 2020 Jan; 255():105423. PubMed ID: 31982082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
    Hammond HH; Ames MK; Domenig O; Scansen BA; Yang NT; Wilson MD; Sunshine E; Brunk K; Masters A
    J Vet Intern Med; 2023; 37(3):875-886. PubMed ID: 36951394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
    Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
    Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
    Zhou Q; Wu Z; Li L; Zhou H; Chen Y; Guo S; Guo Y; Ma X; Zhang J; Feng W; Cui X; Qiu C; Xu M; Deng G
    J Proteomics; 2023 Jun; 282():104924. PubMed ID: 37146676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.
    Ku D; Chae Y; Kim C; Koo Y; Lee D; Yun T; Chang D; Kang BT; Yang MP; Kim H
    Am J Vet Res; 2023 Jun; 84(6):. PubMed ID: 37024099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin concentration changes after acute haemorrhage and colloid-mediated reperfusion in anaesthetized dogs.
    Davis J; Raisis AL; Cianciolo RE; Miller DW; Shiel RE; Nabity MB; Hosgood GL
    Vet Anaesth Analg; 2016 May; 43(3):262-70. PubMed ID: 26469528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease.
    Iwasa N; Kumazawa R; Nomura S; Shimizu M; Iwata M; Hara M; Kawabe M; Kobatake Y; Takashima S; Nishii N
    J Vet Intern Med; 2023 Mar; 37(2):412-419. PubMed ID: 36852471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
    Hong HJ; Oh YI; Park SM; An JH; Kim TH; Chae HK; Seo KW; Youn HY
    BMC Vet Res; 2022 Jul; 18(1):261. PubMed ID: 35790968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary neutrophil gelatinase-associated lipocalin in dogs with stable or progressive kidney disease.
    Kim YM; Polzin DJ; Rendahl A; Granick JL
    J Vet Intern Med; 2019 Mar; 33(2):654-661. PubMed ID: 30767290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM; Jeong DM; Kang MH; Kim SG; Han JI; Park HM
    Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.